Tumor necrosis factor induces pathogenic mitochondrial ROS in tuberculosis through reverse electron transport.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 35737799.
- Also identified by DOI 10.1126/science.abh2841 and PMC identifier 7612974.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Tumor necrosis factor (TNF) is a critical host resistance factor against tuberculosis. However, excess TNF produces susceptibility by increasing mitochondrial reactive oxygen species (mROS), which initiate a signaling cascade to cause pathogenic necrosis of mycobacterium-infected macrophages. In zebrafish, we identified the mechanism of TNF-induced mROS in tuberculosis. Excess TNF in mycobacterium-infected macrophages elevates mROS production by reverse electron transport (RET) through complex I. TNF-activated cellular glutamine uptake leads to an increased concentration of succinate, a Krebs cycle intermediate. Oxidation of this elevated succinate by complex II drives RET, thereby generating the mROS superoxide at complex I. The complex I inhibitor metformin, a widely used antidiabetic drug, prevents TNF-induced mROS and necrosis of <i>Mycobacterium tuberculosis</i>-infected zebrafish and human macrophages; metformin may therefore be useful in tuberculosis therapy.
Medical subject headings
- Electron Transport Complex I
- Macrophages
- Metformin
- Mycobacterium tuberculosis
- Reactive Oxygen Species
- Tuberculosis
- Tumor Necrosis Factor-alpha